BusinessActinium Pharmaceuticals to Present at 29th Annual ROTH ConferenceBy Nasdaq OMXMar 7, 2017, 12:01 PM UTC
BusinessActinium Announces Expansion of Intellectual Property Portfolio with Notice of Allowance for U.S. Patent Related to Actimab-A, Actimab-M and the Company’s Technology PlatformBy Nasdaq OMXFeb 28, 2017, 12:01 PM UTC
BusinessActinium Announces Expansion of Intellectual Property Portfolio with Notice of Allowance for U.S. Patent Related to Actimab-A, Actimab-M and the Company’s Technology PlatformBy Nasdaq OMXFeb 28, 2017, 12:01 PM UTC
BusinessActinium Pharmaceuticals Announces Active Presence at the BMT Tandem MeetingsBy Nasdaq OMXFeb 23, 2017, 12:01 PM UTC
BusinessActinium Pharmaceuticals Announces Active Presence at the BMT Tandem MeetingsBy Nasdaq OMXFeb 23, 2017, 12:01 PM UTC
BusinessActinium Pharmaceuticals Announces Hiring of Steven Price to Position of Vice President, Clinical and Commercial StrategyBy Nasdaq OMXFeb 21, 2017, 12:01 PM UTC
BusinessActinium Pharmaceuticals Announces Hiring of Steven Price to Position of Vice President, Clinical and Commercial StrategyBy Nasdaq OMXFeb 21, 2017, 12:01 PM UTC
BusinessActinium Pharmaceuticals to Attend the BMT Tandem Meetings, the Combined Annual Meetings of Two Leading Transplant OrganizationsBy Nasdaq OMXFeb 14, 2017, 12:03 PM UTC
